{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:20:24Z","timestamp":1791274824849,"version":"4.1.0"},"reference-count":19,"publisher":"BMJ","issue":"6663","license":[{"start":{"date-parts":[[1988,12,17]],"date-time":"1988-12-17T00:00:00Z","timestamp":598320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,12,17]]},"abstract":"<jats:p>Two patients with acute major, disabling cerebral infarction with presumed middle cerebral artery occlusion were treated with the clot specific thrombolytic agent tissue plasminogen activator roughly three and a half hours after the onset of symptoms. Both patients had a normal computed tomography (CT) scan before treatment. No appreciable systemic bleeding complications occurred, apart from bruising. One patient had bleeding into the subarachnoid space from a microscopic angioma, which was found at necropsy. Haematological monitoring of the two patients showed pronounced fibrinogenolysis and alpha 2 antiplasmin consumption in one. One patient showed transient improvement during the infusion. In both cases extensive infarction, partly haemorrhagic in one, with massive concomitant oedema was found on repeated CT. Both patients deteriorated and eventually died as a consequence of transtentorial herniation. In the one patient who came to necropsy a moderate, probably pre-existing smooth stenosis of the ipsilateral carotid artery was found, all cerebral vessels being patent. It is concluded that thrombolytic treatment with a clot specific agent such as tissue plasminogen activator started three to four hours after a major ischaemic stroke may be hazardous, not because of haemorrhagic transformation of the original ischaemia but because early reperfusion may promote massive, potentially fatal cerebral oedema.<\/jats:p>","DOI":"10.1136\/bmj.297.6663.1571","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"1571-1574","source":"Crossref","is-referenced-by-count":84,"title":["Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke."],"prefix":"10.1136","volume":"297","author":[{"given":"P. J.","family":"Koudstaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1988,12,17]]},"reference":[{"key":"ref_1","first-page":"57","article-title":"The management of cerebrovascular diseases","author":"Marshall, J.","year":"1976","unstructured":"Marshall J. The management of cerebrovascular diseases. Oxford: Blackwell Scicntific, 1976:57-9."},{"key":"ref_2","first-page":"154","article-title":"Thrombolytic treatment in ccrebrosvascular thrombosis","volume":"1961","author":"Herndon, R.M.; Nelson, J.N.; Johnson, J.F.; Meyer, J.S.","unstructured":"Herndon RM, Nelson JN, Johnson JF, Meyer JS. Thrombolytic treatment in ccrebrosvascular thrombosis. In: Macmillan RL, Mustard JF, eds. Anticoagulants andfibrinolvsis. Philadelphia: Lea and Febiger, 1961:154-64.","journal-title":"Philadelphia: Lea and Febiger; andfibrinolvsis"},{"key":"ref_3","article-title":"Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase","volume-title":"Cerebral I ascidiar Diseases. Fourth Printceton conference","author":"Meyer, J.S.; Gilroy, J.; Barnhart, M.E.; Johnson, J.F.","year":"200-13.","unstructured":"Meyer JS, Gilroy J, Barnhart ME, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase. In: Millikan CH, Siekert W, Whishant JP, eds. Cerebral I ascidiar Diseases. Fourth Printceton conference. New York: Grune and Stratton, 1964:200-13."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.STR.7.2.135","article-title":"A pilot study of urokinase therapy in cerebral infarction","volume":"7","author":"Fletcher, A.P.; Alkjearsig, N.; Mi, Lewis","year":"1976","unstructured":"Fletcher AP, Alkjearsig N, Lewis Mi, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976;7:135-42.","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.STR.17.4.595","article-title":"Thrombolyrtic therapy in stroke","volume":"17","author":"GJ, Del Zoppo; H, Zeumer; LA, Harker","year":"1986","unstructured":"Del Zoppo GJ, Zeumer H, Harker LA. Thrombolyrtic therapy in stroke. Stroke 1986;17:595-607.","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archneur.1987.00520190052017","article-title":"Thrombolvsis and stroke. Past and future","volume":"4","author":"Sloan, M.A.","year":"1987","unstructured":"Sloan MA. Thrombolvsis and stroke. Past and future. Arch Neurol 1987;4:748-68.","journal-title":"Arch Neurol"},{"key":"ref_7","first-page":"287","article-title":"Survey of progress: vascular recanalizing techniques in iinterxvetitional neuroradiology.,7 Neurol","volume":"231","author":"Zeumer, H.","year":"1985","unstructured":"Zeumer H. Survey of progress: vascular recanalizing techniques in iinterxvetitional neuroradiology.,7 Neurol 1985;231:287-94."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/291590a0","article-title":"Thrombolysis by huiman tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus","volume":"291","author":"Matsuo 0, Rijken DC, Collen D","year":"1981","unstructured":"Matsuo 0, Rijken DC, Collen D. Thrombolysis by huiman tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature 1981;291: 590-1.","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1172\/JCI110778","article-title":"Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus and route of administration","volume":"71","author":"Collen, D.; Stassen, J.M.; Verstraete, M.","year":"1983","unstructured":"Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus and route of administration. J Clin Invest 1983;71:368-76.","journal-title":"J Clin Invest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings","volume":"312","author":"Group, T.I.M.I.Study","year":"1985","unstructured":"TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl3r Med 1985;312:932-6.","journal-title":"N Engl3r Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(85)92208-1","article-title":"Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator","volume":"i:","author":"Verstraete, M.; Bernard, R.; Bory, M.","year":"1985","unstructured":"Verstraete M, Bernard R, Bory M, et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet 1985;i:842-7.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(85)90523-9","article-title":"Double-blind randomized trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction","volume":"ii:","author":"Verstraete, M.; Bleifeld, W.; Brower, R.W.","year":"1985","unstructured":"Verstraete M, Bleifeld W, Brower RW, et al. Double-blind randomized trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet 1985;ii:965-9.","journal-title":"Lancet"},{"key":"ref_13","first-page":"133","article-title":"Tissue plasminogen activator therapy for embolic stroke","volume":"17","author":"Zivin, J.","year":"1986","unstructured":"Zivin J. Tissue plasminogen activator therapy for embolic stroke. Stroke 1986;17: 133.","journal-title":"Stroke"},{"issue":"17","key":"ref_14","first-page":"10","article-title":"Thrombolytic therapy in a baboon model of acute stroke","volume":"1986","author":"GJ, Del Zoppo; BR, Copeland; TA, Waltz","unstructured":"Del Zoppo GJ, Copeland BR, Waltz TA, et al. Thrombolytic therapy in a baboon model of acute stroke. Stroke 1986:17(suppl 1): 10.","journal-title":"Stroke"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3171\/jns.1987.67.3.0394","article-title":"Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.j","volume":"67","author":"Papadopoulos, S.M.; Chandler, W.F.; Salamat, M.S.; Topol, E.J.; Sackellares, J.C.","year":"1987","unstructured":"Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.j Neurosurg 1987;67:394-8.","journal-title":"Neurosurg"},{"key":"ref_16","article-title":"Lysis of basilar artery occlusion with tissue plasminogen activator","author":"Th, Henze; A, Boeer; U, Tebbe; J, Romatowski","year":"1987","unstructured":"Henze Th, Boeer A, Tebbe U, Romatowski J. Lysis of basilar artery occlusion with tissue plasminogen activator. Lancet 1987;ii: 1391.","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens","volume":"17","author":"Clauss, A.","year":"1957","unstructured":"Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol (Basel) 1957;17:237-46.","journal-title":"Acta Haematol (Basel)"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00005072-197905000-00003","article-title":"Early and late mechanisms of increased vascular permeability following experimental cerebral infarction","volume":"38","author":"Petito, C.K.","year":"1979","unstructured":"Petito CK. Early and late mechanisms of increased vascular permeability following experimental cerebral infarction. ] Neuropathol Exp Neurol 1979;38:222-34.","journal-title":"Neuropathol Exp Neurol"},{"key":"ref_19","first-page":"133","article-title":"Very early therapy for cerebral infarction with tissue plasminogen activator","volume":"19","author":"Brott, T.; Haley, E.C.; ILevy, D.E.","year":"1988","unstructured":"Brott T, Haley EC, ILevy DE, et al. Very early therapy for cerebral infarction with tissue plasminogen activator [Abstract]. Stroke 1988; 19:133.","journal-title":"Stroke"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.297.6663.1571","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.297.6663.1571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:05:38Z","timestamp":1765479938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.297.6663.1571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12,17]]},"references-count":19,"journal-issue":{"issue":"6663","published-online":{"date-parts":[[1988,12,17]]},"published-print":{"date-parts":[[1988,12,17]]}},"alternative-id":["10.1136\/bmj.297.6663.1571"],"URL":"https:\/\/doi.org\/10.1136\/bmj.297.6663.1571","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,12,17]]}}}